Weizhong Gu Selected Research

Weizhong Gu Research Topics

Disease

11	Infections 06/2023 - 04/2005
7	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2023 - 01/2015
6	Proteinuria 05/2024 - 02/2015
6	Neoplasms (Cancer) 03/2023 - 10/2014
4	Inflammation (Inflammations) 06/2023 - 10/2018
2	Neuroblastoma 12/2023 - 03/2023
2	Lung Injury 06/2023 - 10/2018
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 02/2023 - 01/2019
2	Pathologic Constriction (Stenosis) 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 01/2022 - 01/2017
2	Hematuria 01/2021 - 09/2016
2	Ischemic Stroke 01/2019 - 10/2014
2	Body Weight (Weight, Body) 10/2018 - 11/2007
2	Vomiting 12/2015 - 07/2015
2	Pulmonary Hypertension 11/2014 - 06/2005
2	Biliary Atresia 04/2005 - 11/2004
1	IGA Glomerulonephritis (IGA Nephropathy) 05/2024
1	Dent Disease 12/2023
1	Dent disease 1 12/2023
1	Atrophy 11/2023
1	Asthma (Bronchial Asthma) 02/2023
1	Necrotizing Enterocolitis 01/2022
1	Coinfection 01/2022
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2022
1	Lymphangioma (Cavernous Lymphangioma) 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 09/2021
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 09/2021
1	Microphthalmos 01/2021
1	Sinusitis 01/2021
1	Chorioamnionitis 01/2021
1	Arachnoid Cysts (Intracranial Arachnoid Cysts) 01/2021
1	Brucellosis (Malta Fever) 01/2021
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2021
1	Glomerulonephritis 01/2021
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2021
1	Stroke (Strokes) 01/2021
1	Human Influenza (Influenza) 01/2021
1	Wilms Tumor (Wilm's Tumor) 01/2021
1	Mesoblastic Nephroma (Congenital Mesoblastic Nephroma) 10/2020
1	Tuberous Sclerosis (Bourneville's Disease) 05/2020
1	Glomus Tumor (Glomus Tumors) 05/2020

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2012
4	SteroidsIBA 09/2016 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 06/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 06/2023
2	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 12/2023 - 07/2015
2	GlucocorticoidsIBA 11/2023 - 01/2022
2	Indicators and Reagents (Reagents)IBA 03/2023 - 01/2015
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 01/2021
2	Peroxidase (Myeloperoxidase)IBA 01/2022 - 01/2021
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 01/2021
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 06/2005
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2018
2	Therapeutic UsesIBA 01/2021 - 11/2007
2	OccludinIBA 01/2021 - 07/2015
2	Viral AntigensIBA 01/2021 - 04/2005
2	CateninsIBA 11/2019 - 07/2015
2	Insulin (Novolin)FDA Link 11/2019 - 01/2012
2	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 01/2019 - 03/2012
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2024
1	ChloridesIBA 12/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2023
1	ParaffinIBA 12/2023
1	Formaldehyde (Formol)FDA Link 12/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023
1	SuspensionsIBA 06/2023
1	Long Noncoding RNAIBA 06/2023
1	UbiquitinIBA 02/2023
1	EnzymesIBA 02/2023
1	OvalbuminIBA 02/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Sirtuin 1IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Myeloblastin (Proteinase 3)IBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	AutoantibodiesIBA 09/2021
1	Annexin A2 (Annexin II)IBA 09/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Gold Colloid (Colloidal Gold)IBA 01/2021
1	CarrageenanIBA 01/2021
1	Claudin-1IBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Thymidine Monophosphate (TMP)IBA 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2021
1	enhanced green fluorescent proteinIBA 01/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	OligosaccharidesIBA 01/2021
1	Phosphotransferases (Kinase)IBA 10/2020
1	RolipramIBA 07/2020
1	trans-sodium crocetinate (crocetin)IBA 05/2020

Therapy/Procedure

7	Therapeutics 11/2023 - 04/2014
2	Drug Therapy (Chemotherapy) 03/2023 - 04/2014
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2022 - 01/2021
1	Nephrectomy 01/2021